343 related articles for article (PubMed ID: 23557870)
1. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
Krowka MJ; Wiesner RH; Heimbach JK
J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
Raevens S; Boret M; De Pauw M; Fallon MB; Van Vlierberghe H
Hepatology; 2021 Sep; 74(3):1674-1686. PubMed ID: 33636019
[TBL] [Abstract][Full Text] [Related]
3. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
Mandell MS
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
[TBL] [Abstract][Full Text] [Related]
4. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
Krowka MJ; Mandell MS; Ramsay MA; Kawut SM; Fallon MB; Manzarbeitia C; Pardo M; Marotta P; Uemoto S; Stoffel MP; Benson JT
Liver Transpl; 2004 Feb; 10(2):174-82. PubMed ID: 14762853
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary complications in chronic liver disease.
Machicao VI; Balakrishnan M; Fallon MB
Hepatology; 2014 Apr; 59(4):1627-37. PubMed ID: 24089295
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for variceal hemorrhage due to recurrent of hereditary hemorrhagic telangiectasia in a liver transplant.
Cura MA; Postoak D; Speeg KV; Vasan R
J Vasc Interv Radiol; 2010 Jan; 21(1):135-9. PubMed ID: 19926494
[TBL] [Abstract][Full Text] [Related]
7. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
DuBrock HM; Del Valle KT; Krowka MJ
Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
Lerut J; Orlando G; Adam R; Sabbà C; Pfitzmann R; Klempnauer J; Belghiti J; Pirenne J; Thevenot T; Hillert C; Brown CM; Gonze D; Karam V; Boillot O;
Ann Surg; 2006 Dec; 244(6):854-62; discussion 862-4. PubMed ID: 17122610
[TBL] [Abstract][Full Text] [Related]
9. Evolving dilemmas and management of portopulmonary hypertension.
Krowka MJ
Semin Liver Dis; 2006 Aug; 26(3):265-72. PubMed ID: 16850376
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary complications of cirrhosis.
Singh C; Sager JS
Med Clin North Am; 2009 Jul; 93(4):871-83, viii. PubMed ID: 19577119
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
Martínez-Palli G; Taurà P; Balust J; Beltrán J; Zavala E; Garcia-Valdecasas JC
Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
[TBL] [Abstract][Full Text] [Related]
13. Portopulmonary hypertension: Results from a 10-year screening algorithm.
Krowka MJ; Swanson KL; Frantz RP; McGoon MD; Wiesner RH
Hepatology; 2006 Dec; 44(6):1502-10. PubMed ID: 17133488
[TBL] [Abstract][Full Text] [Related]
14. Development of hepatopulmonary syndrome and portopulmonary hypertension in a paediatric liver transplant patient.
Shah T; Isaac J; Adams D; Kelly D;
Pediatr Transplant; 2005 Feb; 9(1):127-31. PubMed ID: 15667626
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Assessment of the Liver Transplant Recipient.
Panackel C; Fawaz M; Jacob M; Raja K
J Clin Exp Hepatol; 2023; 13(5):895-911. PubMed ID: 37693254
[TBL] [Abstract][Full Text] [Related]
16. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
Krowka MJ
Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vascular abnormalities in cirrhosis.
Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary complications of liver cirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax].
Halank M; Strassburg CP; Hoeper MM
Internist (Berl); 2010 Mar; 51 Suppl 1():255-63. PubMed ID: 20098977
[TBL] [Abstract][Full Text] [Related]
19. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
20. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
Therapondos G; Wong F
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
